IPP Bureau
China Pharma submits plan of compliance to NYSE American
By IPP Bureau - July 18, 2022
The company was directed to submit a plan of compliance by July 15, 2022
Sumitomo Pharma Oncology receives Orphan Drug Designation for DSP-0390 for the treatment of brain cancer
By IPP Bureau - July 18, 2022
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
By IPP Bureau - July 16, 2022
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Merck and Orion collaborate for the development and commercialization of ODM-208
By IPP Bureau - July 16, 2022
Orion to receive an upfront payment of USD 290 million
UPS Healthcare revolutionizes prioritized shipping with UPS Premier
By IPP Bureau - July 16, 2022
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Cellutions BioStorage, a research-to-launch Cryopreservation Bank, inaugurated
By IPP Bureau - July 16, 2022
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
India Health Link join hands with Canopi
By IPP Bureau - July 16, 2022
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network
By IPP Bureau - July 16, 2022
Mittal will be driving expansion of the provider network across India
Enveda appoints Vanitha Sekar as Chief Business Officer
By IPP Bureau - July 16, 2022
She joins Enveda from Gilead Sciences
Enveric Biosciences advances drug development for mental health indications
By IPP Bureau - July 16, 2022
Advancing to IND-enabling studies with multiple drug candidates
Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality
By IPP Bureau - July 15, 2022
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Syngene signs 10-year biologics manufacturing agreement with Zoetis
By IPP Bureau - July 15, 2022
Syngene's collaboration with Zoetis started in 2011
Healthcare Triangle closes $6.5 million private placement
By IPP Bureau - July 15, 2022
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Cipla Health signs agreement to acquire Endura Mass
By IPP Bureau - July 15, 2022
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
By IPP Bureau - July 15, 2022
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
